Vaccines | Notable Papers Published in 2024 in the “Epidemiology” Section

1. “Herpes Zoster Vaccine Uptake and Active Campaign Impact, a Multicenter Retrospective Study in Italy”
by Andrea Ceccarelli, Federica Tamarri, Raffaella Angelini, Elizabeth Bakken, Ilaria Concari, Elsa Giannoccaro, Giada Domeniconi, Michela Morri, Chiara Reali, Francesca Righi et al.
Vaccines 2024, 12(1), 51; https://doi.org/10.3390/vaccines12010051
Full text available online: https://www.mdpi.com/2076-393X/12/1/51

2. “Sustaining the Elimination of Measles, Rubella and Congenital Rubella Syndrome in the Americas, 2019–2023: From Challenges to Opportunities”
by Gloria Rey-Benito, Desirée Pastor, Alvaro Whittembury, Regina Durón, Carmelita Pacis-Tirso, Pamela Bravo-Alcántara, Claudia Ortiz and Jon Andrus
Vaccines 2024, 12(6), 690; https://doi.org/10.3390/vaccines12060690
Full text available online: https://www.mdpi.com/2076-393X/12/6/690

3. “Possible Paths to Measles Eradication: Conceptual Frameworks, Strategies, and Tactics”
by Amy K. Winter and William J. Moss
Vaccines 2024, 12(7), 814; https://doi.org/10.3390/vaccines12070814
Full text available online: https://www.mdpi.com/2076-393X/12/7/814

4. “Congenital Rubella Syndrome Does Not Increase with Introduction of Rubella-Containing Vaccine”
by Kurt Frey
Vaccines 2024, 12(7), 811; https://doi.org/10.3390/vaccines12070811
Full text available online: https://www.mdpi.com/2076-393X/12/7/811

5. “The Global Measles and Rubella Laboratory Network Supports High-Quality Surveillance”
by Paul A. Rota, Roger Evans, Myriam Corinne Ben Mamou, Gloria Rey-Benito, Lucky Sangal, Annick Dosseh, Amany Ghoniem, Charles R. Byabamazima, Maurice Demanou, Raydel Anderson et al.
Vaccines 2024, 12(8), 946; https://doi.org/10.3390/vaccines12080946
Full text available online: https://www.mdpi.com/2076-393X/12/8/946

6. “An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity”
by Emma Chang-Rabley, Menno C. van Zelm, Emily E. Ricotta and Emily S. J. Edwards
Vaccines 2024, 12(6), 675; https://doi.org/10.3390/vaccines12060675
Full text available online: https://www.mdpi.com/2076-393X/12/6/675

7. “Assessment of Epidemiological Trend of Influenza-Like Illness in Italy from 2010/2011 to 2023/2024 Season: Key Points to Optimize Future Vaccination Strategies against Influenza”
by Sara Boccalini and Angela Bechini
Vaccines 2024, 12(8), 841; https://doi.org/10.3390/vaccines12080841
Full text available online: https://www.mdpi.com/2076-393X/12/8/841

8. “Determinants of Systemic SARS-CoV-2-Specific Antibody Responses to Infection and to Vaccination: A Secondary Analysis of Randomised Controlled Trial Data”
by Juana Claus, Thijs ten Doesschate, Esther Taks, Priya A. Debisarun, Gaby Smits, Rob van Binnendijk, Fiona van der Klis, Lilly M. Verhagen, Marien I. de Jonge, Marc J. M. Bonten et al.
Vaccines 2024, 12(6), 691; https://doi.org/10.3390/vaccines12060691
Full text available online: https://www.mdpi.com/2076-393X/12/6/691

9. “Measles and Rubella Diagnostic and Classification Challenges in Near- and Post-Elimination Countries”
by Thomas D. Filardo, Stephen N. Crooke, Bettina Bankamp, Kelley Raines, Adria D. Mathis, Tatiana M. Lanzieri, R. Suzanne Beard, Ludmila Perelygina, David E. Sugerman and Paul A. Rota
Vaccines 2024, 12(6), 697; https://doi.org/10.3390/vaccines12060697
Full text available online: https://www.mdpi.com/2076-393X/12/6/697

10. “Serosurveillance for Measles and Rubella”
by Allison M. Brady, Elina El-Badry, Eriko Padron-Regalado, Nicole A. Escudero González, Daniel L. Joo, Paul A. Rota and Stephen N. Crooke
Vaccines 2024, 12(7), 816; https://doi.org/10.3390/vaccines12070816
Full text available online: https://www.mdpi.com/2076-393X/12/7/816